Search

Search results for: ""

Showing 131-140 of 454 results

News - Helsinn Group and MEI Pharma Announce First Patient Dosed in Phase 2 Dose-Optimization Study of Pracinostat and Azacitidine in Myelodysplastic Syndrome 14/06/2017 1:43pm

News - Helsinn Investment Fund leads the financial round in GreenBone 16/06/2017 9:23am

News - Helsinn Group Announces Upcoming Presentation of Phase III data in NEPA (netupitant/palonestron) at MASCC/ISOO Congress in Washington DC 20/06/2017 2:11pm

Data demonstrates the non-inferiority of NEPA versus an aprepitant (APR)/granisetron (GRAN) regimen

Website - Uploads

Website - icon scope

Website - icon scope2

Website - icon factory

Website - icon handshake

Website - icon case

Website - Employees

Copyright © 2017 Helsinn Healthcare SA. All rights reserved. Helsinn Group Cyber-Duck